Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126209421 | 12620942 | 1 | I | 201606 | 20160722 | 20160804 | 20160804 | EXP | CH-ACTELION-A-CH2016-140018 | ACTELION | 69.00 | YR | E | F | Y | 0.00000 | 20160804 | OT | CH | CH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126209421 | 12620942 | 1 | PS | OPSUMIT | MACITENTAN | 1 | Oral | UNK | U | U | 204410 | TABLET | |||||||
| 126209421 | 12620942 | 2 | SS | NOVALGIN | METAMIZOLE SODIUM | 1 | Oral | UNK | Y | U | 0 | ||||||||
| 126209421 | 12620942 | 3 | SS | RIOCIGUAT | RIOCIGUAT | 1 | Unknown | UNK | 0 | ||||||||||
| 126209421 | 12620942 | 4 | SS | PANTOZOL | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, UNK | U | U | 0 | 40 | MG | ||||||
| 126209421 | 12620942 | 5 | SS | IMUREK | AZATHIOPRINE | 1 | Oral | 50 MG, UNK | U | U | 0 | 50 | MG | ||||||
| 126209421 | 12620942 | 6 | SS | TORASEMIDE | TORSEMIDE | 1 | Oral | 0 | |||||||||||
| 126209421 | 12620942 | 7 | SS | REMODULIN | TREPROSTINIL | 1 | Intravenous drip | UNK, CONT INFUS | 0 | ||||||||||
| 126209421 | 12620942 | 8 | SS | MARCOUMAR | PHENPROCOUMON | 1 | Oral | UNK, PRN | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126209421 | 12620942 | 1 | Pulmonary arterial hypertension |
| 126209421 | 12620942 | 2 | Arthralgia |
| 126209421 | 12620942 | 3 | Pulmonary arterial hypertension |
| 126209421 | 12620942 | 4 | Product used for unknown indication |
| 126209421 | 12620942 | 5 | Product used for unknown indication |
| 126209421 | 12620942 | 6 | Product used for unknown indication |
| 126209421 | 12620942 | 7 | Pulmonary arterial hypertension |
| 126209421 | 12620942 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126209421 | 12620942 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126209421 | 12620942 | Agranulocytosis | |
| 126209421 | 12620942 | Anaemia macrocytic | |
| 126209421 | 12620942 | Asthenia | |
| 126209421 | 12620942 | Dyspnoea | |
| 126209421 | 12620942 | Haemoglobin decreased | |
| 126209421 | 12620942 | Pyrexia | |
| 126209421 | 12620942 | Respiratory failure | |
| 126209421 | 12620942 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126209421 | 12620942 | 1 | 201408 | 0 | ||
| 126209421 | 12620942 | 2 | 20160620 | 20160630 | 0 | |
| 126209421 | 12620942 | 3 | 20140614 | 0 |